Form 8-K - Current report:
SEC Accession No. 0001493152-24-049823
Filing Date
2024-12-12
Accepted
2024-12-12 17:13:56
Documents
27
Period of Report
2024-12-12
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48891
2 ex2-1.htm EX-2.1 6854
3 ex23-1.htm EX-23.1 3115
4 ex99-2.htm EX-99.2 80325
5 ex2-1_001.jpg GRAPHIC 1355783
6 ex2-1_002.jpg GRAPHIC 1078129
7 ex2-1_003.jpg GRAPHIC 1381227
8 ex2-1_004.jpg GRAPHIC 1447088
9 ex2-1_005.jpg GRAPHIC 1059018
10 ex2-1_006.jpg GRAPHIC 1132392
11 ex2-1_007.jpg GRAPHIC 1162435
12 ex2-1_008.jpg GRAPHIC 562259
13 GRAPHIC ex23-1_001.jpg GRAPHIC 1551595
14 GRAPHIC ex23-1_002.jpg GRAPHIC 999793
  Complete submission text file 0001493152-24-049823.txt   16479840

Data Files

Seq Description Document Type Size
15 XBRL SCHEMA FILE etst-20241212.xsd EX-101.SCH 3039
16 XBRL LABEL FILE etst-20241212_lab.xml EX-101.LAB 34240
17 XBRL PRESENTATION FILE etst-20241212_pre.xml EX-101.PRE 24181
30 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3671
Mailing Address 8950 SW 74TH CT SUITE 101 MIAMI FL 33156
Business Address 8950 SW 74TH CT SUITE 101 MIAMI FL 33156 (786) 375-7281
Earth Science Tech, Inc. (Filer) CIK: 0001538495 (see all company filings)

EIN.: 454267181 | State of Incorp.: FL | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-55000 | Film No.: 241545934
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)